SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-207816
Filing Date
2022-08-01
Accepted
2022-08-01 08:31:48
Documents
15
Period of Report
2022-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d379263d8k.htm   iXBRL 8-K 32384
2 EX-99.1 d379263dex991.htm EX-99.1 12252
7 GRAPHIC g379263g0730101726968.jpg GRAPHIC 4016
  Complete submission text file 0001193125-22-207816.txt   218737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20220801.xsd EX-101.SCH 4532
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20220801_def.xml EX-101.DEF 13941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20220801_lab.xml EX-101.LAB 23491
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20220801_pre.xml EX-101.PRE 14903
9 EXTRACTED XBRL INSTANCE DOCUMENT d379263d8k_htm.xml XML 5936
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 221122913
SIC: 2834 Pharmaceutical Preparations